We are live on ! Find out more
LFM

Lumina Fund Management Portfolio holdings

AUM $164M
1-Year Est. Return 27.72%
This Fund
S&P 500
This Quarter Est. Return
+8.32%
1 Year Est. Return
+27.72%
3 Year Est. Return
+28.12%
5 Year Est. Return
+101.22%
10 Year Est. Return
+153.06%
AUM
$217M
AUM Growth
-$46.8M
Cap. Flow
+$3.19M
Cap. Flow %
1.47%
Top 10 Hldgs %
91.59%
Holding
45
New
13
Increased
4
Reduced
8
Closed
5

Top Sells

Rank Stock Value
1
ALXN
Alexion Pharmaceuticals
ALXN
+$627K
2
EEFT icon
Euronet Worldwide
EEFT
+$622K
3
INMD icon
InMode
INMD
+$579K
4
CVS icon
CVS Health
CVS
+$434K
5
AMGN icon
Amgen
AMGN
+$369K

Sector Composition

Rank Sector Weight
1 Miscellaneous 83.03%
2 Technology 8.1%
3 Healthcare 6.14%
4 Communication Services 1.23%
5 Consumer Discretionary 0.98%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SPY icon
1
State Street SPDR S&P 500 ETF Trust
SPY
$815B
$152M 70.06%
355,901
+4,900
+1% +$2.05M
QQQ icon
2
Invesco QQQ Trust
QQQ
$489B
$16M 7.35%
45,100
SPY icon
3
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$815B
$10.6M 4.89%
25,000
-175,000
-88% -$73M
AAPL icon
4
Apple
AAPL
$4.67T
$8.77M 4.03%
64,000
NXPI icon
5
NXP Semiconductors
NXPI
$57.5B
$2.37M 1.09%
11,500
QCOM icon
6
Qualcomm
QCOM
$180B
$2.26M 1.04%
15,800
+500
+3% +$67.6K
BABA icon
7
Alibaba
BABA
$281B
$2.09M 0.96%
9,200
+3,000
+48% +$667K
CVS icon
8
CVS Health
CVS
$124B
$1.67M 0.77%
20,000
-5,300
-21% -$434K
TMO icon
9
Thermo Fisher Scientific
TMO
$227B
$1.61M 0.74%
3,200
PARA
10
DELISTED
Paramount Global Class B
PARA
$1.44M 0.66%
31,925
VYM icon
11
Vanguard High Dividend Yield ETF
VYM
$82.8B
$1.44M 0.66%
13,702
AVGO icon
12
Broadcom
AVGO
$1.7T
$1.43M 0.66%
30,000
AMGN icon
13
Amgen
AMGN
$236B
$1.22M 0.56%
5,000
-1,500
-23% -$369K
PFE icon
14
Pfizer
PFE
$162B
$1.18M 0.54%
30,000
REGN icon
15
Regeneron Pharmaceuticals
REGN
$85.2B
$1M 0.46%
1,800
BMY icon
16
Bristol-Myers Squibb
BMY
$136B
$1M 0.46%
15,000
MRK icon
17
Merck
MRK
$371B
$972K 0.45%
12,500
-600
-5% -$44.6K
ILMN icon
18
Illumina
ILMN
$33B
$946K 0.44%
2,056
-514
-20% -$207K
MA icon
19
Mastercard
MA
$507B
$913K 0.42%
2,500
SGEN
20
DELISTED
Seagen Inc. Common Stock
SGEN
$789K 0.36%
+5,000
New +$743K
SAIC icon
21
Saic
SAIC
$5.31B
$746K 0.34%
8,500
BIIB icon
22
Biogen
BIIB
$32.6B
$727K 0.33%
2,100
-1,000
-32% -$303K
XLNX
23
DELISTED
Xilinx Inc
XLNX
$723K 0.33%
+5,000
New +$636K
TSM icon
24
TSMC
TSM
$2.22T
$721K 0.33%
+6,000
New +$703K
BIDU icon
25
Baidu
BIDU
$33.7B
$714K 0.33%
3,500

Similar funds

Lumina Fund Management's Q2 2021 Portfolio in Review

As of Q2 2021, Lumina Fund Management held 45 positions worth $217M, down 18% from $264M the previous quarter. Its ten largest holdings account for 92% of the portfolio.

Lumina Fund Management's Q2 2021 filing shows 13 new, 4 increased, 8 reduced and 5 closed positions. Its largest new stake was Seagen Inc. Common Stock: 5,000 shares worth $789K. The largest sale was Alexion Pharmaceuticals, an estimated $627K.

By sector, the portfolio is most concentrated in Miscellaneous at 83% of assets, down from 88% a quarter earlier, followed by Technology and Healthcare.

  • Lumina Fund Management's largest Q2 2021 buy was Seagen Inc. Common Stock: 5,000 shares worth $789K.
  • Lumina Fund Management added most to State Street SPDR S&P 500 ETF Trust in Q2 2021, an estimated $2.05M increase.
  • Lumina Fund Management's biggest Q2 2021 reduction was CVS Health, cutting an estimated $434K.
  • Lumina Fund Management fully exited Alexion Pharmaceuticals in Q2 2021, selling an estimated $627K.
  • Lumina Fund Management's ten largest holdings make up 92% of its $217M portfolio in Q2 2021.
  • Lumina Fund Management opened 13 new positions and closed 5 in Q2 2021.
  • Lumina Fund Management's portfolio value fell 18% quarter-over-quarter to $217M.

Based on Lumina Fund Management's 13F filing for Q2 2021, filed 13 Aug 2021.